Abstract
Type 2 diabetes Mellitus (T2DM) is characterized by chronically increased blood glucose levels, which is associated with impairment of the inflammatory and oxidative state and dyslipidaemia. Although it is considered a world heath concern and one of the most studied diseases, we are still pursuing an effective therapy for both the pathophysiological mechanisms and the complications. Curcumin, a natural compound found in the rhizome of Curcuma longa, is well known for its numerous biological activities, as demonstrated by several studies supporting that curcumin possesses hypoglycaemic, hypolipidemic, anti-inflammatory and antioxidant properties, among others. These effects have been explored to the attenuation of hyperglycaemia and progression of DM complications, being appointed as a potential therapeutic approach. Besides its strong intrinsic activity, the polyphenol has low bioavailability, compromising its therapeutic efficacy. In order to overcome this limitation, several chemical strategies have been applied to curcumin, such as drug delivery systems, chemical manipulation and the use of adjuvant therapies. Given the promising results obtained with curcumin derivative, in this review we discuss not only the therapeutic targets of curcumin, but also its most recently developed analogues and their efficacy in the management of T2DM pathophysiology and complications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abd Allah ESH, Gomaa AMS (2015) Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1. Appl Physiol Nutr Metab 40:1061–1067. https://doi.org/10.1139/apnm-2015-0145
Abdel-Mageid AD, Abou-Salem MES, Salaam NMHA, El-Garhy HAS (2018) The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. Phytomedicine 43:126–134. https://doi.org/10.1016/j.phymed.2018.04.039
Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M (2019) The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Phyther Res 33:1374–1383. https://doi.org/10.1002/ptr.6328
Akbar MU, Zia KM, Akash MSH, Nazir A, Zuber M, Ibrahim M (2018) In-vivo anti-diabetic and wound healing potential of chitosan/alginate/maltodextrin/pluronic-based mixed polymeric micelles: curcumin therapeutic potential. Int J Biol Macromol 120:2418–2430. https://doi.org/10.1016/j.ijbiomac.2018.09.010
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818. https://doi.org/10.1021/mp700113r
Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G (2019) Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: a randomized double-blind placebo- controlled clinical trial. Complement Ther Med 43:253–260. https://doi.org/10.1016/j.ctim.2019.02.014
Assis RP, Arcaro CA, Gutierres VO, Oliveira JO, Costa PI, Baviera AM, Brunetti IL (2017) Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int J Mol Sci 18:1–20. https://doi.org/10.3390/ijms18040332
Bale S, Khurana A, Reddy ASS, Singh M, Godugu C (2016) Overview on therapeutic applications of microparticulate drug delivery systems. Crit Rev Ther Drug Carrier Syst 33:309–361. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2016015798
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820. https://doi.org/10.1038/414813a
Bulboacă AE, Porfire AS, Tefas LR, Boarescu PM, Bolboacă SD, Stănescu IC, Bulboacă AC, Dogaru G (2019) Liposomal curcumin is better than curcumin to alleviate complications in experimental diabetic mellitus. Molecules 24:846. https://doi.org/10.3390/molecules24050846
Calle MC, Fernandez ML (2012) Inflammation and type 2 diabetes. Diabetes Metab 38:183–191. https://doi.org/10.1016/j.diabet.2011.11.006
Cao L, Zhi D, Han J, Kumar Sah S, Xie Y (2019) Combinational effect of curcumin and metformin against gentamicin-induced nephrotoxicity: Involvement of antioxidative, anti-inflammatory and antiapoptotic pathway. J Food Biochem 43:e12836. https://doi.org/10.1111/jfbc.12836
Chen H, Yang X, Lu K, Lu C, Zhao Y, Zheng S, Li J, Huang Z, Huang Y, Zhang Y, Liang G (2017) Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice. Toxicol Lett 278:48–58. https://doi.org/10.1016/j.toxlet.2017.07.212
Cicero AFG, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C (2019) Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur J Nutr 59:477–483. https://doi.org/10.1007/s00394-019-01916-7
Das KK, Razzaghi-Asl N, Tikare SN, Di Santo R, Costi R, Messore A, Pescatori L, Crucitti GC, Jargar JG, Dhundasi SA, Saso L (2016) Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats. J Enzyme Inhib Med Chem 31:99–105. https://doi.org/10.3109/14756366.2015.1004061
Daugherty DJ, Marquez A, Calcutt NA, Schubert D (2018) A novel curcumin derivative for the treatment of diabetic neuropathy. Neuropharmacology 129:26–35. https://doi.org/10.1016/j.neuropharm.2017.11.007
Defronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R (2015) Type 2 diabetes mellitus. Nat Rev Dis Prim. https://doi.org/10.1038/nrdp.2015.19
Diabetes Care (2019) Classification and diagnosis of diabetes: standards of medical care in diabetes –2019. Diabetes Care. American Diabetes Association, Arlington, pp S13–S28. https://doi.org/10.2337/dc19-S002
Ding L, Li J, Song B, Xiao X, Zhang B, Qi M, Huang W, Yang L, Wang Z (2016) Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway. Toxicol Appl Pharmacol 304:99–109. https://doi.org/10.1016/j.taap.2016.05.011
El-Far YM, Zakaria MM, Gabr MM, El Gayar AM, Eissa LA, El-Sherbiny IM (2017) Nanoformulated natural therapeutics for management of streptozotocin-induced diabetes: potential use of curcumin nanoformulation. Nanomedicine 12:1689–1711. https://doi.org/10.2217/nnm-2017-0106
El-Naggar ME, Al-Joufi F, Anwar M, Attia MF, El-Bana MA (2019) Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats. Coll Surf B Biointerfaces 177:389–398. https://doi.org/10.1016/j.colsurfb.2019.02.024
Elburki MS, Moore DD, Terezakis NG, Zhang Y, Lee HM, Johnson F, Golub LM (2017) A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects. J Periodontal Res 52:186–200. https://doi.org/10.1111/jre.12381
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V (2019) Diabetic neuropathy. Nat Rev Dis Prim 5:1–18. https://doi.org/10.1038/s41572-019-0092-1
Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 7:313–324. https://doi.org/10.2174/157339911797415585
Ganugula R, Arora M, Jaisamut P, Wiwattanapatapee R, Jørgensen HG, Venkatpurwar VP, Zhou B, Rodrigues Hoffmann A, Basu R, Guo S, Majeti NVRK (2017) Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus. Br J Pharmacol 174:2074–2084. https://doi.org/10.1111/bph.13816
GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117–171. https://doi.org/10.1016/S0140-6736(14)61682-2
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
Gutierres VO, Campos ML, Arcaro CA, Assis RP, Baldan-Cimatti HM, Peccinini RG, Paula-Gomes S, Kettelhut IC, Baviera AM, Brunetti IL (2015) Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evidence-based Complement Altern Med 2015:1–13. https://doi.org/10.1155/2015/678218
Han J, Oh J, Ihm SH, Lee M (2016) Peptide micelle-mediated curcumin delivery for protection of islet β-cells under hypoxia. J Drug Target 24:618–623. https://doi.org/10.3109/1061186X.2015.1132220
Hewlings S, Kalman D (2017) Curcumin: a review of its’ effects on human health. Foods 6:92. https://doi.org/10.3390/foods6100092
Ho C, Hsu YC, Lei CC, Mau SC, Shih YH, Lin CL (2016) Curcumin rescues diabetic renal fibrosis by targeting superoxide-mediated wnt signaling pathways. Am J Med Sci 351:286–295. https://doi.org/10.1016/j.amjms.2015.12.017
Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G (2019) The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. Diabetol Metab Syndr 11:1–8. https://doi.org/10.1186/s13098-019-0437-7
Huang Y (2017) IDF Diabetes Atlas 8th edition. International Diabetes Federation, Brussels
Kadam S, Kanitkar M, Dixit K, Deshpande R, Seshadri V, Kale V (2018) Curcumin reverses diabetes-induced endothelial progenitor cell dysfunction by enhancing MnSOD expression and activity in vitro and in vivo. J Tissue Eng Regen Med 12:1594–1607. https://doi.org/10.1002/term.2684
Kato M, Nishikawa S, Ikehata A, Dochi K, Tani T, Takahashi T, Imaizumi A, Tsuda T (2017) Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol Nutr Food Res 61:1–6. https://doi.org/10.1002/mnfr.201600471
Kaur G, Invally M, Chintamaneni M (2016) Influence of piperine and quercetin on antidiabetic potential of curcumin. J Complement Integr Med 13:247–255. https://doi.org/10.1515/jcim-2016-0016
Kim BH, Lee ES, Choi R, Nawaboot J, Lee MY, Lee EY, Kim HS, Chung CH (2016) Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J 57:664–673. https://doi.org/10.3349/ymj.2016.57.3.664
Lao CD, Iv MTR, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE, Ruffin IVMT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6:1–4. https://doi.org/10.1186/1472-6882-6-10
Li C, Miao X, Lou Y, Lu Z, Adhikari BK, Wang Y, Liu Q, Sun J, Wang Y (2018) Cardioprotective effects of the novel curcumin analogue C66 in diabetic mice is dependent on JNK2 inactivation. J Cell Mol Med 22:6314–6326. https://doi.org/10.1111/jcmm.13924
Li C, Miao X, Wang S, Adhikari BK, Wang X, Sun J, Liu Q, Tong Q, Wang Y (2018) Novel curcumin C66 that protects diabetes-induced aortic damage was associated with suppressing JNK2 and upregulating Nrf2 expression and function. Oxid Med Cell Longev 2018:12. https://doi.org/10.1155/2018/5783239
Li J, Wang P, Ying J, Chen Z, Yu S (2016) Curcumin attenuates retinal vascular leakage by inhibiting calcium/calmodulin-dependent protein kinase II activity in streptozotocin-induced diabetes. Cell Physiol Biochem 39:1196–1208. https://doi.org/10.1159/000447826
Li Y, Zhang ZZ (2018) Sustained curcumin release from PLGA microspheres improves bone formation under diabetic conditions by inhibiting the reactive oxygen species production. Drug Des Devel Ther 12:1453–1466. https://doi.org/10.2147/DDDT.S154334
Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, Zhai G (2016) Oral bioavailability of curcumin: problems and advancements. J Drug Target 24:694–702. https://doi.org/10.3109/1061186X.2016.1157883
Lu M, Yin N, Liu W, Cui X, Chen S, Wang E (2017) Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling. Biomed Res Int 2017:10. https://doi.org/10.1155/2017/1516985
Ma J, Liu J, Yu H, Chen Y, Wang Q, Xiang L (2016) Beneficial effect of metformin on nerve regeneration and functional recovery after sciatic nerve crush injury in diabetic rats. Neurochem Res 41:1130–1137. https://doi.org/10.1007/s11064-015-1803-y
Maithilikarpagaselvi N, Sridhar MG, Swaminathan RP, Zachariah B (2016) Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: potential role of serine kinases. Chem Biol Interact 244:187–194. https://doi.org/10.1016/j.cbi.2015.12.012
Matafome P, Seiça R (2017) Function and dysfunction of adipose tissue. Adv Neurobiol 19:3–31. https://doi.org/10.1007/978-3-319-63260-5_1
Matafome P, Sena C, Seiça R (2013) Methylglyoxal, obesity, and diabetes. Endocrine 43:472–484. https://doi.org/10.1007/s12020-012-9795-8
Matafome P, Rodrigues T, Sena C, Seiça R (2017) Methylglyoxal in metabolic disorders: facts, myths, and promises. Med Res Rev 37:368–403. https://doi.org/10.1002/med.21410
Maugeri A, Mazzone MG, Giuliano F, Vinciguerra M, Basile G, Barchitta M, Agodi A (2018) Curcumin modulates DNA methyltransferase functions in a cellular model of diabetic retinopathy. Oxid Med Cell Longev 2018:5407482. https://doi.org/10.1155/2018/5407482
Meng B, Li J, Cao H, Cao JL (2013) Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr Pharm Des 19:2101–2113. https://doi.org/10.2174/1381612811319110011
Mirhafez SR, Farimani AR, Dehhabe M, Bidkhori M, Hariri M, Motlagh Ghouchani BFN, Abdollahi F (2019) Effect of phytosomal curcumin on circulating levels of adiponectin and leptin in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled clinical trial. J Gastrointest Liver Dis 28:183–189. https://doi.org/10.15403/jgld-179
Mirhafez SR, Rezai A, Dehabeh M, Gh BFNM, Bidkhori M, Sahebkar A, Hariri M, (2019) Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease. Int J Vitam Nutr Res. https://doi.org/10.1024/0300-9831/a000629
Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:S35–S42. https://doi.org/10.1016/j.jacc.2008.09.055
Pan M, Huang T-M, Lin J-K (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–494
Pan Y, Zhao D, Yu N, An T, Miao J, Mo F, Gu Y, Zhang D, Gao S, Jiang G (2017) Curcumin improves glycolipid metabolism through regulating peroxisome proliferator activated receptor γ signalling pathway in high-fat diet-induced obese mice and 3t3-l1 adipocytes. R Soc Open Sci 4:170917. https://doi.org/10.1098/rsos.170917
Panahi Y, Khalili N, Sahebi E, Namazi S, Atkin SL, Majeed M, Sahebkar A (2017) Curcuminoids plus piperine modulate adipokines in Type 2 diabetes mellitus. Curr Clin Pharmacol 12:253–258. https://doi.org/10.2174/1574884713666180104095641
Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, Sahebkar A (2017) Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial. Drug Res (Stuttg) 67:244–251. https://doi.org/10.1055/s-0043-100019
Paolino D, Vero A, Cosco D, Pecora TMG, Cianciolo S, Fresta M, Pignatello R (2016) Improvement of oral bioavailability of curcumin upon microencapsulation with methacrylic copolymers. Front Pharmacol 7:1–9. https://doi.org/10.3389/fphar.2016.00485
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:1–33. https://doi.org/10.1186/s12951-018-0392-8
Pavari F, Mingione A, Brasacchio C, Soldati L (2019) Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients 11:1837. https://doi.org/10.3390/nu11081837
Potenza MA, Gagliardi S, Nacci C, Carratu’ MR, Montagnani MMRC (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16:94–112. https://doi.org/10.2174/092986709787002853
Prasad S, Tyagi AK, Aggarwal BB (2014) Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46:2–18. https://doi.org/10.4143/crt.2014.46.1.2
Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A (2016) Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phyther Res 1548:1540–1548. https://doi.org/10.1002/ptr.5659
Rask-Madsen C, King GL (2013) Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17:20–33. https://doi.org/10.1016/j.cmet.2012.11.012
Rivera-Mancía S, Lozada-García MC, Pedraza-Chaverri J (2015) Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Eur J Pharmacol 756:30–37. https://doi.org/10.1016/j.ejphar.2015.02.045
Rodrigues T, Matafome P, Seiça R (2014) A vascular piece in the puzzle of adipose tissue dysfunction: mechanisms and consequences. Arch Physiol Biochem 120:1–11. https://doi.org/10.3109/13813455.2013.838971
Santos-Parker JR, Strahler TR, Bassett CJ, Bispham NZ, Chonchol MB, Seals DR (2017) Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging 9:187–208. https://doi.org/10.18632/aging.101149
Schalkwijk CG, Stehouwer CDA (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109:143–159. https://doi.org/10.1042/CS20050025
Song Z, Revelo X, Shao W, Tian L, Zeng K, Lei H, Sun HS, Woo M, Winer D, Jin T (2018) Dietary curcumin intervention targets mouse white adipose tissue inflammation and brown adipose tissue UCP1 expression. Obesity 26:547–558. https://doi.org/10.1002/oby.22110
Su L, Wang Y, Chi H (2017) Effect of curcumin on glucose and lipid metabolism, FFAs and TNF-α in serum of type 2 diabetes mellitus rat models. Saudi J Biol Sci 24:1776–1780. https://doi.org/10.1016/j.sjbs.2017.11.011
Thota RN, Dias CB, Abbott KA, Acharya SH, Garg ML (2018) Curcumin alleviates postprandial glycaemic response in healthy subjects: a cross-over, randomized controlled study. Sci Rep 8:1–8. https://doi.org/10.1038/s41598-018-32032-x
Tong F, Chai R, Jiang H, Dong B (2018) In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles. Int J Nanomed 13:1945–1962. https://doi.org/10.2147/IJN.S153763
Wu H, Kong L, Tan Y, Epstein PN, Zeng J, Gu J, Liang G, Kong M, Chen X, Miao L, Cai L (2016) C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. Diabetologia 59:1558–1568. https://doi.org/10.1007/s00125-016-3958-8
Xu X, Cai Y, Yu Y (2018) Effects of a novel curcumin derivative on the functions of kidney in streptozotocin-induced type 2 diabetic rats. Inflammopharmacology 26:1257–1264. https://doi.org/10.1007/s10787-018-0449-1
Yang F, Yu J, Ke F, Lan M, Li D, Tan K, Ling J, Wang Y, Wu K, Li D (2018) Curcumin alleviates diabetic retinopathy in experimental diabetic rats. Ophthalmic Res 60:43–54. https://doi.org/10.1159/000486574
Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Anal Technol Biomed Life Sci 853:183–189. https://doi.org/10.1016/j.jchromb.2007.03.010
Zhang X, Liang D, Guo L, Liang W, Jiang Y, Li H, Zhao Y, Lu S, Chi ZH (2015) Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Mol Med Rep 12:1347–1355. https://doi.org/10.3892/mmr.2015.3556
Zhao L, Pan Y, Peng K, Wang Z, Li J, Li D, Tong C, Wang Y, Liang G (2015) Inhibition of 11β-HsD1 by LG13 improves glucose metabolism in type 2 diabetic mice. J Mol Endocrinol 55:119–131. https://doi.org/10.1530/JME-14-0268
Zheng Y, Ley SH, Hu FB (2017) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98. https://doi.org/10.1038/nrendo.2017.151
Acknowledgements
This manuscript was supported by the Portuguese Foundation of Science and Technology (Strategic Projects UID/NEU/04539/2013 and UID/NEU/04539/2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Oliveira, S., Monteiro-Alfredo, T., Silva, S. et al. Curcumin derivatives for Type 2 Diabetes management and prevention of complications. Arch. Pharm. Res. 43, 567–581 (2020). https://doi.org/10.1007/s12272-020-01240-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-020-01240-3